Microbial metabolites alleviate Aß-induced alterations of intestinal epithelial barrier and enteric nervous system connectivity
Journal of Functional Foods · 2025-12 · 135 · 107095
DOI: 10.1016/j.jff.2025.107095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Foods, 2025-12. Verfasst von Rodrigue Brossaud und 11 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regional Council of Pays de la Loire, Conseil Régional de Bretagne, Institut National de la Santé et de la Recherche Médicale.
Abstract (Originalsprache)
Amyloid-ß (Aß) induced alterations in gut functions, such as reduced motility and compromised barrier integrity contribute to age-related frailty. Therefore, developing fermentation-based products to prevent age-related gut disorders represents a major therapeutic interest. Primary cultures of enteric nervous system and Caco-2 monolayers were exposed to Aß oligomers following pretreatment with individual or a combination of candidate microbial derived metabolites (butyrate, gamma-aminobutyric acid, and indole derivatives), or a candidate metabolite-enriched fermented dairy product that we subsequently developed. Results showed that individual metabolites significantly preserved markers of neuronal connectivity (beta-tubulin III and synaptophysin) and stabilized tight junction proteins (zonula occludens-1 and occludin), reducing Aß-induced dysfunction. Furthermore, enhanced protective effects of the fermented dairy products enriched with microbial metabolites were observed, suggesting a promising dietary strategy for supporting gut health in aging and Alzheimer's disease, although in vivo validation is needed. Left: Pathological aging promotes gut microbiota dysbiosis and amyloid pathology, which increases intestinal epithelial barrier (IEB) permeability and enteric nervous system (ENS) dysconnectivity. Right: normal aging preserves gut microbiota homesostasis and beneficial microbial metabolites, which prevents gut amyloidosis, protects IEB and reinforces ENS connectivity. • Amyloid-ß (Aß) alters enteric nervous system connectivity and intestinal epithelial permeability in vitro. • Butyrate, GABA, and tryptophan derivatives counteract Aß-induced synaptophysin decrease. • A fermented dairy product enriched with indole derivatives, GABA and SCFAs mitigates Aß-induced alterations of ENS connectivity and IEB integrity.
Förderung
- Regional Council of Pays de la Loire
- Conseil Régional de Bretagne
- Institut National de la Santé et de la Recherche Médicale
- Université de Nantes
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Zitieren
APA
Brossaud, R., Moullé, V. S., Giblaine, M., Even, S., Maillard, M., Chevalier, S., Oullier, T., Guédon, E., Loir, Y. L., Cissé, M., Falentin, H., & Neunlist, M. (2025). Microbial metabolites alleviate Aß-induced alterations of intestinal epithelial barrier and enteric nervous system connectivity. Journal of Functional Foods, 135, 107095. https://doi.org/10.1016/j.jff.2025.107095
Vancouver
Brossaud R, Moullé VS, Giblaine M, Even S, Maillard M, Chevalier S, et al. Microbial metabolites alleviate Aß-induced alterations of intestinal epithelial barrier and enteric nervous system connectivity. Journal of Functional Foods. 2025;135:107095. doi:10.1016/j.jff.2025.107095
BibTeX
@article{Brossaud2025,
author = {Brossaud, Rodrigue and Moullé, Valentine S. and Giblaine, Marina and Even, Sergine and Maillard, Marie-Bernadette and Chevalier, Séverine and Oullier, Thibauld and Guédon, Eric and Loir, Yves Le and Cissé, Moustapha and Falentin, Hélène and Neunlist, Michel},
title = {Microbial metabolites alleviate Aß-induced alterations of intestinal epithelial barrier and enteric nervous system connectivity},
journal = {Journal of Functional Foods},
year = {2025},
volume = {135},
pages = {107095},
doi = {10.1016/j.jff.2025.107095}
}
EUVIMED